Latest Form 4 insider transactions
NASDAQ
Hyperscale Data, Inc. reported changes in beneficial ownership of Alzamend Neuro, Inc. common stock on July 31, 2026.
NASDAQ
Milton C Ault Iii, a Director of Alzamend Neuro, Inc., received 7,500 shares of common stock on July 31, 2026.
NASDAQ
WYFI
Whitefiber, INCJustin Zhu, Chief Financial Officer of WhiteFiber, Inc., received 4,219 shares of common stock on August 1, 2026.
NASDAQ
WYFI
Whitefiber, INCIchi Shih, a Director of WhiteFiber, Inc., received 4,657 shares of common stock on August 3, 2026.
NASDAQ
Wolfe Repass, Chief Financial Officer of FTAC Emerald Acquisition Corp., sold 1,180 shares of common stock on July 31, 2026 for $0.47 per share.
Miguel Matias Galuccio, Chief Executive Officer and a Director of Vista Energy, S.A.B. de C.V., reported a transaction in 281,186 shares of common stock on July 13, 2026.
Juan Maria Garoby, Chief Technology Officer of Vista Energy, S.A.B. de C.V., reported a transaction in 61,861 shares of common stock on July 13, 2026.
NASDAQ
Thomas J Dickman, Chief Technology Officer of FTAC Emerald Acquisition Corp., sold 5 shares of common stock on July 31, 2026 for $0.47 per share.
NASDAQ
William Brian Poppic Reeves, Chief Executive Officer and 10% owner of FTAC Emerald Acquisition Corp., sold 5,082 shares of common stock on July 31, 2026 for $0.47 per share.
Pinto Pablo Manuel Vera, Chief Financial Officer of Vista Energy, S.A.B. de C.V., reported a transaction in 61,861 shares of common stock on July 13, 2026.
Alejandro Chernacov, Strategic Planning and IRO of Vista Energy, S.A.B. de C.V., reported a transaction in 56,238 shares of common stock on July 13, 2026.
NASDAQ
Howard T Slayen, a Director of Aehr Test Systems, sold 20,000 shares of common stock on August 4, 2026 for $108.30 per share.
NYSE
SLQT
Selectquote, INCRyan Moore Clement, Chief Financial Officer of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCSarah Taylor Anderson, (See Remarks) of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCStephanie D. Fisher, Chief Accounting Officer of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCTimothy Robert Danker, CHIEF EXECUTIVE OFFICER and a Director of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCJoshua Brandon Matthews, President, SelectQuote Senior of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCRobert Clay Grant, PRESIDENT of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCWilliam Thomas Grant Iii, CHIEF OPERATING OFFICER of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
SLQT
Selectquote, INCDaniel Allen Boulware, GENERAL COUNSEL AND SECRETARY of SelectQuote, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Angeliki Frangou, See Remarks, a Director and 10% owner of Navios Maritime Partners L.P., purchased 2,524 shares of common stock on July 31, 2026.
NASDAQ
Laura Oliphant, a Director of Aehr Test Systems, reported a transaction in 500 shares of common stock on August 4, 2026.
NASDAQ
PHUN
Phunware, INCChristopher D. Olive, Chief Legal Officer of Phunware, Inc., reported a transaction in 519 shares of common stock on August 4, 2026.
NASDAQ
PHUN
Phunware, INCJohn Brendhan Botkin, Vice President, Accounting of Phunware, Inc., reported a transaction in 414 shares of common stock on August 4, 2026.
OQB
Black Robe Capital LLC and 1 other reported changes in beneficial ownership of Inhibitor Therapeutics, Inc. common stock on July 1, 2026.
NYSE
Laura Lawson, EVP, Chief People Officer and a Director of UWM Holdings Corp, reported multiple transactions in common stock on July 31, 2026.
NYSE
Form 4: C3.ai CEO Sells Shares
Thomas M Siebel, CEO and Chairman of the Board, a Director and 10% owner of C3.ai, Inc., sold 139,500 shares of common stock on August 2, 2026 for $9.61 per share.
NASDAQ
IMMR
Immersion CORPWilliam C Martin, Chief Strategy Officer and a Director of Immersion Corp, received 5,640 shares of common stock on July 31, 2026.
NASDAQ
CGC II Sponsor LLC and 2 others reported changes in beneficial ownership of Cartesian Growth Corp II common stock on August 3, 2026.
NASDAQ
Freddy I Rivas, Chief Credit Officer of Coastal Financial Corp, reported a transaction in 166 shares of common stock on August 3, 2026.